CLDX Financials
Celldex Therapeutics Inc - Financial statements & key metrics
Stock Price
$39.24
Market Cap
$2.35B
P/E Ratio
-16.0
EPS
$-3.38
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$7.02M
Gross Profit
-
Operating Income
-
Net Income
-
EPS (Diluted)
$-2.45
Balance Sheet Highlights
Total Assets
$792.34M
Total Liabilities
$45.34M
Shareholders Equity
-
Cash & Equivalents
$28.36M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-157.78M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-9859.2%
ROE
-32.4%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CLDX revenue?
CLDX's most recent quarterly revenue was $7.02M. Annual revenue can be calculated by summing the four most recent quarters.
Is CLDX profitable?
Check CLDX's income statement for profitability data.
What is CLDX market cap?
CLDX has a market capitalization of $2.35B, making it a mid-cap stock.
Does CLDX have debt?
View CLDX's balance sheet for debt information.
What is CLDX cash flow?
Cash flow data is available in the full financial statements.